Skip to main content
. 2025 Jul 25;15(16):8377–8403. doi: 10.7150/thno.115860

Scheme 1.

Scheme 1

The engineered EVs platform by conjugating EVs with the tumor-homing peptide iRGD encapsulated with miR-150-3p, utilizing annexin A2 (ANXA2) to enhance selective RNA incorporation.